Compounds > creatine
Page last updated: 2024-10-17

creatine and HMN (Hereditary Motor Neuropathy) Proximal Type I

creatine has been researched along with HMN (Hereditary Motor Neuropathy) Proximal Type I in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Wadman, RI3
van der Pol, WL2
Bosboom, WM3
Asselman, FL1
van den Berg, LH4
Iannaccone, ST4
Vrancken, AF4
Bosboom, W1
Wokke, JH3

Reviews

4 reviews available for creatine and HMN (Hereditary Motor Neuropathy) Proximal Type I

ArticleYear
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2020, 01-06, Volume: 1

    Topics: Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; gamma-Aminobutyr

2020
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Amines; Creatine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Phenylbu

2009
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids;

2011
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids;

2012